| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/16/2002 | US6420115 Monitoring binding activities of nuleotide sequences; obtain nucleotide sequences, incubate with probes, detect intensity of bound cmplex |
| 07/16/2002 | US6420113 Chimeric polyclonal antibodies |
| 07/16/2002 | US6420110 Methods and reagents for isolating biologically active peptides |
| 07/16/2002 | US6420107 Assay for identifying anti-viral agents specific for protein-coated double-stranded DNA viruses |
| 07/16/2002 | US6420105 Method for analyzing molecular expression or function in an intact single cell |
| 07/16/2002 | US6419933 Genetic engineered polypeptide |
| 07/16/2002 | US6419929 Genetic engineering |
| 07/16/2002 | US6419927 Method for reducing adverse effects of a human 70kDa mediator which results from endotoxin stimulation of macrophages |
| 07/16/2002 | US6419925 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 07/16/2002 | US6419923 Filariid nematode cysteine protease proteins, and uses thereof |
| 07/16/2002 | US6419896 Non-invasive approach for assessing tumors in living animals |
| 07/16/2002 | US6419881 Combinatorial arrays of organometallic compounds and catalysts |
| 07/16/2002 | US6419880 Systems and methods for catalyst reactivation |
| 07/16/2002 | US6419822 Systems and methods for sensing red blood cell hematocrit |
| 07/16/2002 | US6419808 Hydrocarbon sensor |
| 07/16/2002 | US6419361 Spectral bio-imaging of the eye |
| 07/16/2002 | US6418805 Constituent sensing system |
| 07/16/2002 | US6418783 Handheld sensing apparatus |
| 07/16/2002 | US6418781 System for analyzing trace amounts of impurities in gases |
| 07/16/2002 | US6418780 Ceramic gas sensor and an apparatus for measuring waste gas using the sensor and controlling an amount of fuel to burn |
| 07/16/2002 | US6418778 Gas detector equipped with feedback function |
| 07/16/2002 | CA2276358C Method of determining pulp properties |
| 07/16/2002 | CA2239360C G-csf analog compositions and methods |
| 07/16/2002 | CA2148569C Analytical system for monitoring a substance to be analyzed in patient blood |
| 07/16/2002 | CA2148537C Stable freeze-dried formulation comprising a protein; assay kit |
| 07/16/2002 | CA2081559C Determination of analytes in biological fluids in the presence of substances interfering with assays therefor |
| 07/16/2002 | CA2068804C Electrolytic cell and process for the labeling of proteins and peptides |
| 07/16/2002 | CA2024063C Antibodies directed against nerve growth factor-like peptides |
| 07/16/2002 | CA2018172C Solid phase assay for use with a physical developer |
| 07/12/2002 | CA2346583A1 Detection methods |
| 07/11/2002 | WO2002054417A1 Plate-like magnetic particles |
| 07/11/2002 | WO2002054339A1 Devices and methods to image objects |
| 07/11/2002 | WO2002054326A2 Method for organizing and depicting biological elements |
| 07/11/2002 | WO2002054088A2 Contrast enhancement agent for magnetic resonance imaging |
| 07/11/2002 | WO2002054086A1 Method of compensating for drift in gas sensing equipment |
| 07/11/2002 | WO2002054084A1 A method for diagnosing atrophic gastritis |
| 07/11/2002 | WO2002054083A2 Alpha synuclein aggregation assays |
| 07/11/2002 | WO2002054082A1 Use of a pure allergen component |
| 07/11/2002 | WO2002054081A2 Proteins, genes and their use for diagnosis and treatment of kidney response |
| 07/11/2002 | WO2002054080A2 Proteins, genes and their use for diagnosis and treatment of vascular response |
| 07/11/2002 | WO2002054079A2 Proteins, genes and their use for diagnosis and treatment of cardiac response |
| 07/11/2002 | WO2002054077A2 Validating biological molecules as drug targets by metal-ion chelates in animal test models |
| 07/11/2002 | WO2002054076A2 Sensor for luminescence optical determination of an analyte |
| 07/11/2002 | WO2002054075A1 Elemental analysis of tagged biologically active materials |
| 07/11/2002 | WO2002054074A2 Recognition of tumor-specific gene products in cancer |
| 07/11/2002 | WO2002054073A2 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/11/2002 | WO2002054072A2 Assay to determine efficacy of treatment for mycobacterial infection |
| 07/11/2002 | WO2002054071A1 Method and apparatus using a surface-selective nonlinear optical technique |
| 07/11/2002 | WO2002054070A1 Protein chips, method producing it and detection system of the protein chips, and operating method of the detection system |
| 07/11/2002 | WO2002054069A1 Assays for taste receptor cell specific ion channel |
| 07/11/2002 | WO2002054068A1 Method of reusing dna-immobilization substrate |
| 07/11/2002 | WO2002054067A2 Detection of analytes |
| 07/11/2002 | WO2002054066A2 Non-apoptotic forms of cell death and methods of modulation |
| 07/11/2002 | WO2002054065A2 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 07/11/2002 | WO2002054064A2 Method for screening for progesterone receptor isoform-specific ligands |
| 07/11/2002 | WO2002054062A2 Reference standards and processes for determining the purity or stability of amlodipine maleate |
| 07/11/2002 | WO2002054061A1 Nir determination of flour baking properties |
| 07/11/2002 | WO2002054060A2 Device for analyzing gas |
| 07/11/2002 | WO2002054057A1 Analysis method for detecting three-dimensional trace element distribution patterns and corresponding device for carrying out this method |
| 07/11/2002 | WO2002054054A1 Biosensor |
| 07/11/2002 | WO2002054053A1 Flaw detector |
| 07/11/2002 | WO2002054052A1 Diagnostic instruments and methods for detecting analytes |
| 07/11/2002 | WO2002054045A2 Reagent for luminescence optical determination of an analyte |
| 07/11/2002 | WO2002054044A2 Focused acoustic ejection cell sorting system and method |
| 07/11/2002 | WO2002054041A1 Skin permeable gas collector and skin permeable gas measuring apparatus |
| 07/11/2002 | WO2002054040A1 Portable sampling lance |
| 07/11/2002 | WO2002053778A2 Method for relative quantification of attached nucleic acids |
| 07/11/2002 | WO2002053777A2 Device and method for tracking conditions in an assay |
| 07/11/2002 | WO2002053775A2 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 07/11/2002 | WO2002053773A2 Method for determining skin stress or skin ageing in vitro |
| 07/11/2002 | WO2002053770A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/11/2002 | WO2002053768A2 Dna rapid immune detection methods and apparatus |
| 07/11/2002 | WO2002053767A1 Marker, forgery detection agent, method of real/forgery discrimination for product, method of preventing forgery distribution, and product |
| 07/11/2002 | WO2002053761A2 Recombinant protective protein from $i(streptococcus pneumoniae) |
| 07/11/2002 | WO2002053757A1 Hiv-like particles and the use thereof |
| 07/11/2002 | WO2002053749A2 Regulation of human serine-threonine protein kinase |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | WO2002053742A2 Proteins and nucleic acids encoding same |
| 07/11/2002 | WO2002053740A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/11/2002 | WO2002053736A1 Method of examining ability to control nerve cell plasticity |
| 07/11/2002 | WO2002053735A1 Trasncription activation complex and utilization thereof |
| 07/11/2002 | WO2002053733A2 Regulation of human b7-h2 protein |
| 07/11/2002 | WO2002053730A1 Novel potassium channel |
| 07/11/2002 | WO2002053729A1 Bhlh-pas proteins, genes thereof and utilization of the same |
| 07/11/2002 | WO2002053728A2 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | WO2002053723A2 Degradation and detection of tse infectivity |
| 07/11/2002 | WO2002053717A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/11/2002 | WO2002053713A2 Cloning of a human sulfotransferase |
| 07/11/2002 | WO2002053712A2 Avian hepatitis e virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis e |
| 07/11/2002 | WO2002053710A1 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 07/11/2002 | WO2002053596A2 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | WO2002053595A1 Group 2 allergen specific ige-fabs and igg molecules and use thereof |
| 07/11/2002 | WO2002053594A2 Inhibitors of memapsin 2 and use thereof |
| 07/11/2002 | WO2002053593A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/11/2002 | WO2002053592A1 Novel polypeptide and dna thereof |
| 07/11/2002 | WO2002053247A2 Technique for rapid prediction of long-term hydrophobic organic contaminant desorption rates |
| 07/11/2002 | WO2002053231A2 Method and device for gevondyan and zharov photo-immune- modulating therapy |
| 07/11/2002 | WO2002053171A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity |
| 07/11/2002 | WO2002053152A1 Composition containing flavonoids for treatment brain disorders |
| 07/11/2002 | WO2002053030A1 Method and device for evaluating a physiological state of a human organism |